SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-22-195613
Filing Date
2022-07-18
Accepted
2022-07-18 06:19:39
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-1/A d342801ds1a.htm S-1/A 353896
2 EX-1.1 d342801dex11.htm EX-1.1 160493
3 EX-4.5 d342801dex45.htm EX-4.5 107750
4 EX-4.6 d342801dex46.htm EX-4.6 105960
5 EX-5.1 d342801dex51.htm EX-5.1 18979
6 EX-23.2 d342801dex232.htm EX-23.2 2358
7 EX-FILING FEES d342801dexfilingfees.htm EX-FILING FEES 32686
8 GRAPHIC g342801g53q79.jpg GRAPHIC 45236
9 GRAPHIC g342801new.jpg GRAPHIC 11377
10 GRAPHIC g342801snap0012.jpg GRAPHIC 6566
  Complete submission text file 0001193125-22-195613.txt   870615
Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-266072 | Film No.: 221088104
SIC: 2836 Biological Products, (No Diagnostic Substances)